Old Web
English
Sign In
Acemap
>
authorDetail
>
Charu Gandotra
Charu Gandotra
Center for Drug Evaluation and Research
Internal medicine
Medicine
Confidence interval
Odds ratio
Interquartile range
3
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Heart Failure Population with Therapeutic Response to Sacubitril/Valsartan, Spironolactone and Candesartan: FDA Perspective.
2021
Therapeutic Innovation & Regulatory Science
Charu Gandotra
Jennifer Clark
Ququan Liu
Fortunato Senatore
Martin Rose
Jialu Zhang
Norman Stockbridge
Show All
Source
Cite
Save
Citations (1)
Risk of Covid-19-Related Hospitalization and More Severe Outcomes in Medicare Beneficiaries Treated with Renin-Angiotensin-Aldosterone System Inhibitors for Hypertension
2021
Journal of General Internal Medicine
David J. Graham
Hector S. Izurieta
Stella G. Muthuri
Di Zhang
Alexander T. Sandhu
Yun Lu
Yueqin Zhao
Yuhui Feng
Efe Eworuke
Hai Lyu
Charu Gandotra
Elizabeth R. Smith
Armen Avagyan
Michael Wernecke
Jeffrey A. Kelman
Richard A. Forshee
Thomas E. MaCurdy
Show All
Source
Cite
Save
Citations (1)
Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment.
2021
Joshua D. Wallach
Yihong Deng
Rozalina G. McCoy
Sanket S. Dhruva
Jeph Herrin
Alyssa Berkowitz
Eric C. Polley
Kenneth Quinto
Charu Gandotra
William H. Crown
Peter A. Noseworthy
Xiaoxi Yao
Nilay Shah
Joseph S. Ross
Timothy D. Lyon
Show All
Source
Cite
Save
Citations (1)
1